Sentinel Lymph Note Assessment for endometrial Carcinoma by Transabdominal Laparoscopy or NOTES

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040546

Enrollment

Unknown

Registered

2020-12-01

Start date

2020-12-01

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial carcinoma

Interventions

vNOTEs:vNOTEs

Lap:laporoscopic

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with endometrial carcinoma confirmed by histology; 2. According to the preoperative pathological results and imaging (ultrasound / MRI) risk stratification, the risk groups were low risk/medium risk/medium high risk[ Patients with low-risk endometrial carcinoma stage I endometrioid carcinoma, grade 1-2, =50% myometrial invasion, Lvsi negative; patients with moderate and high-risk endometrial carcinoma: stage I endometrioid, grade 3, 3.0 x 10^9/L; 2) Platelet > 100 x 10^9/L; 3) Creatinine =18 years.

Exclusion criteria

Exclusion criteria: 1. Preoperative pathological report of patients with any histology other than endometrial carcinoma (serous carcinoma, clear cell carcinoma, undifferentiated carcinoma, or carcinosarcoma) 2. Patients with high-risk endometrial carcinoma (stage I endometrioid, grade 3, = 50% myometrial invasion; stage II / III endometrioid carcinoma) were found before the operation 3. Patients with enlarged pelvic or aortic lymph nodes (> 2cm) or positive lymph nodes by histology (CT scan, MRI, or pet CT scan) indicated metastasis 4. Patients with a history of pelvic or abdominal radiotherapy 5. Ultrasound showed that the maximum diameter of the uterus was greater than 12cm 6. Patients with contraindications to surgery or with severe systemic diseases (the specific situation is decided by the researcher) 7. The patient can't stand the lithotomy position for a long time 8. Patients with a poor compliance or long distance can not be fully followed up

Design outcomes

Primary

Measure	Time frame
Number of lymph node biopsies;	—

Secondary

Measure	Time frame
complication;	—

Countries

China

Contacts

Public ContactWang Yanzhou

Southwest Hospital affiliated to the Army Military Medical University

w.y.z@foxmail.com+86 18680893816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026